ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
INVESTORS
[한경 BIO Insight] [Cover Story – part.5] 큐로셀, CAR-T 뛰어넘는 CAR-T 개발
2021/02/23
큐로셀, CAR-T 뛰어넘는 CAR-T 개발 | 한국경제 (hankyung.com)
한경 BIO Insight 이우상 기자
Prev
[이데일리] 단1회 투입으로 2개월만 말기암 완치 ‘기적의 신약’
Next
[히트뉴스] 히터뷰 | CAR-T 치료제 개발 위해 ‘국내 첫 임상’ 시작한 큐로셀[히트뉴스]
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.
